In the Boardroom
Refine Search
Biotechnology
UK-based stem cell therapy company ReNeuron Group has announced the recruitment for a new Chief Executive Officer. 23 April 2014
Pharmaceutical
Pharma major Lupin has announced the appointment of Theresa Stevens as Chief Corporate Development Officer for its global operations. 23 April 2014
Pharmaceutical
Japanese drugmaker Daiichi Sankyo has announced that Ken Keller will join the company as President of its Commercial operations in the United States. 23 April 2014
Pharmaceutical
Swiss drug major Novartis has announced the appointment of Jeff George as Division Head of Alcon and Richard Francis as new Division Head of Sandoz. 22 April 2014
Pharmaceutical
UK-based drug discovery and development company e-Therapeutics has announced the appointment of Steve Medlicott as Finance Director. 22 April 2014
Pharmaceutical
South African drugmaker Adcock Ingram has announced the appointment of Kevin Wakeford (pictured) as Chief Executive Officer, with immediate effect. 22 April 2014
Pharmaceutical
French independent drugmaker Laboratories Servier announced that its founder and president, Jacques Servier, has died at the age of 92. 17 April 2014
Pharmaceutical
The US subsidiary of Japanese drug major Astellas Pharma announced that Jeffrey Bloss has been promoted to the position of senior vice president, medical affairs Americas, Astellas Scientific and Medical Affairs (ASMA), effective April 1. Dr Bloss will serve as a member of the Astellas US management committee. 16 April 2014
Pharmaceutical
New Haven Pharmaceuticals, a privately held specialty pharmaceuticals company, today announced the appointment of Larry Dillaha, to the newly-created position of Executive Vice President Operations. 2 April 2014
Biotechnology
Paul Sekhri has joined French drug major Sanofi as Senior Vice President, Integrated Care effective today. 1 April 2014
Pharmaceutical
USA-based Inovio Pharmaceuticals (NYSE MKT: INO) has announced the appointment of EJ Brandreth as Vice President of Quality. 1 April 2014
Pharmaceutical
Par Pharmaceutical Companies (NYSE: PRX) has announced the appointment of Terrance Coughlin as chief operating officer. 1 April 2014
Biotechnology
French drug major Sanofi has announced the appointment of Anne Beal to the newly created position of Chief Patient Officer. 31 March 2014
Biotechnology
aTyr Pharma, a rare disease biotherapeutics enterprise, has announced the appointment of David Weiner as chief medical officer. 31 March 2014
Biotechnology
Adaptimmune, a biotech company focused on the use of engineered T cells to treat cancer, has announced the full-time appointment of James Noble as chief executive officer. 26 March 2014
Biotechnology
German pharma and chemical major Merck KGaA has announced the promotion of three distinguished internal managers to head the life-science-tools and consumer health divisions as well as its allergy business unit. 26 March 2014
Biotechnology
Angle (AIM:AGL), the specialist medtech company, has appointed Clive Stanway as a Scientific Adviser with immediate effect. 26 March 2014
Pharmaceutical
Novira Therapeutics has announced the appointment of Christian Schade as chief executive officer, effective March 19. 21 March 2014
Pharmaceutical
Japan’s largest drugmaker Takeda Pharmaceutical (TYO: 4502) has announced the appointment of Giles Platford as Head of Commercial Operations, Emerging Markets. 19 March 2014
Pharmaceutical
UK-based company NeRRe Therapeutics, which is focused on the development of neurokinin (NK) receptor antagonists for a range of indications, has announced the appointment of Ian Nicholson as Chief Business Officer (CBO). 19 March 2014
Biotechnology
US biotech Paragon Therapeutics yesterday revealed that biotech industry veteran Susanna High has been appointed as chief executive (CEO). In this newly-created role, Ms High will lead the team’s continued efforts to propel the development of a pipeline of transformative therapies and accelerate their potential impact. 22 November 2024
Biotechnology
US biotech major Amgen has announced that Dr Howard Chang will join the company as senior vice president of research, effective December 16, 2024. 21 November 2024
Pharmaceutical
Anthony Harnden has been appointed as the new chair of the UK’s Medicine and Healthcare products Regulatory Agency (MHRA). 20 November 2024
Biotechnology
Mirai Bio has announced the appointment of Jens Vogel as the company’s president and chief operating officer (COO). 20 November 2024
Biotechnology
Aclaris Therapeutics has announced an exclusive licensing agreement with Biosion for broad rights to two new antibodies. 19 November 2024
Biotechnology
Privately-held US biotech Georgiamune has announced the appointment of Mark Avagliano as chief business officer (CBO). 19 November 2024
Pharmaceutical
New York-based Mind Medicine, a company developing MM120, a form of LSD (lysergide d-tartrate), for mental health conditions, has announced the appointment of Gregg Pratt, as chief regulatory and quality assurance officer. 19 November 2024
Biotechnology
Belgian biotech start-up ExeVir Bio says it has appointed Michael Garrett as its new chief executive (CEO), effective 1 December 2024. 18 November 2024
Biotechnology
ALX Oncology Holdings, a Californian immuno-oncology company, has announced the appointment of Alan Sandler as chief medical officer (CMO). 14 November 2024
Pharmaceutical
US ophthalmology specialist Ocular Therapeutix announced that Namrata Saroj has joined the Company on a full-time basis as chief business officer (CBO). Dr Saroj previously served as development strategy consultant to Ocular since February 2024. 14 November 2024
Biotechnology
VarmX, a Dutch biotech developing innovative approaches for the bypass of direct oral anticoagulants targeting activated factor Xa (FXa DOACs) and inherited coagulation disorders, has appointed industry veteran John Glasspool (pictured, above) as chief executive. 12 November 2024
Biotechnology
French biotech DiogenX, which is focused on regenerating insulin-producing beta cells for the treatment of diabetes, today announces the appointment of Dr Klara Owen as chief medical officer. 12 November 2024
Biotechnology
Rubedo Life Sciences, a US biopharma developing first-in-class therapies targeting senescent cells which drive age-related diseases, has announced the appointment of Frederick C Beddingfield III, as chief executive officer and board director. 11 November 2024
Biotechnology
US clinical-stage drug developer Acumen Pharmaceuticals has appointed Amy Schacterle as chief regulatory officer and head of quality, reporting to Jim Doherty, president and chief development officer at Acumen. 7 November 2024
Biotechnology
Memo Therapeutics, a privately-held Swiss biotech company translating unique responses into superior medicines to treat viral infections and cancer, has appointed a new chief development officer (CDO). 4 November 2024
Biotechnology
Netherlands-based Tessellate BIO, a pre-clinical stage biotech with a focus on novel synthetic lethality approaches, today announced the appointment of Dr Lara Boyd as chief business officer. 4 November 2024
Biotechnology
US biotech major Biogen revealed it has appointed Daniel Quirk as chief medical officer and head of medical affairs. 29 October 2024
Pharmaceutical
Fennec Pharmaceuticals has announced the addition of three new executives to bolster its leadership team as the company prepares for expanded commercial operations. 28 October 2024
Biotechnology
AAVantgarde has announced the appointment of Lauren Kaskiel as chief business officer (CBO). 22 October 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze